{"resourceType":"ValueSet","id":"ti-drug-category-vs","url":"https://gematik.de/fhir/terminology/ValueSet/ti-drug-category-vs","version":"1.0.5-4","name":"TIDrugCategoryVS","title":"TI Arzneimittelkategorien Value Set","status":"active","experimental":false,"date":"2025-05-12","publisher":"gematik GmbH","contact":[{"telecom":[{"system":"url","value":"https://www.gematik.de"}]}],"description":"Das Arzneimittelkategorien Value Set für die TI.","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"DE"}]}],"immutable":false,"compose":{"include":[{"system":"https://gematik.de/fhir/epa-medication/CodeSystem/epa-drug-category-cs"}]},"expansion":{"timestamp":"2025-05-09","contains":[{"system":"https://gematik.de/fhir/epa-medication/CodeSystem/epa-drug-category-cs","code":"00","display":"Arzneimittel oder in die Arzneimittelversorgung nach § 31 SGB V einbezogenes Produkt"},{"system":"https://gematik.de/fhir/epa-medication/CodeSystem/epa-drug-category-cs","code":"01","display":"BtM"},{"system":"https://gematik.de/fhir/epa-medication/CodeSystem/epa-drug-category-cs","code":"02","display":"AMVV § 3a Abs. 1 (Thalidomid o. ä.)"},{"system":"https://gematik.de/fhir/epa-medication/CodeSystem/epa-drug-category-cs","code":"03","display":"Sonstiges"}]}}